Senecioic acid

CAS No. 541-47-9

Senecioic acid( 3-Methylcrotonic Acid | 33-Dimethylacrylic Acid )

Catalog No. M19993 CAS No. 541-47-9

Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Senecioic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).
  • Description
    Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-Methylcrotonic Acid | 33-Dimethylacrylic Acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    541-47-9
  • Formula Weight
    100.12
  • Molecular Formula
    C5H8O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:200 mM
  • SMILES
    C\C(C)=C\C(O)=O
  • Chemical Name
    2-Butenoic acid 3-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Duran M et al. Organic acid excretion in a patient with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: facts and artefacts. Clin Chim Acta. 1978 Dec 1;90(2):187-93.
molnova catalog
related products
  • Dimethoxycurcumin

    Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.

  • PACMA 31

    PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.

  • Angiotensin I/II 1-6

    Angiotensin I/II (1-6) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS) that contains the amino acids 1-6 and is converted from Angiotensin I/II peptide.